Royce & Associates LP Acquires 22,030 Shares of Teleflex Incorporated $TFX

Royce & Associates LP lifted its holdings in Teleflex Incorporated (NYSE:TFX) by 31.5% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 92,030 shares of the medical technology company’s stock after purchasing an additional 22,030 shares during the period. Royce & Associates LP owned 0.21% of Teleflex worth $11,231,000 as of its most recent filing with the SEC.

A number of other institutional investors have also made changes to their positions in TFX. Empowered Funds LLC increased its stake in shares of Teleflex by 15.8% in the first quarter. Empowered Funds LLC now owns 1,684 shares of the medical technology company’s stock worth $233,000 after purchasing an additional 230 shares during the period. Jane Street Group LLC increased its stake in Teleflex by 42.6% during the first quarter. Jane Street Group LLC now owns 6,343 shares of the medical technology company’s stock valued at $877,000 after acquiring an additional 1,895 shares during the period. American Century Companies Inc. increased its stake in Teleflex by 32.7% during the second quarter. American Century Companies Inc. now owns 13,640 shares of the medical technology company’s stock valued at $1,614,000 after acquiring an additional 3,360 shares during the period. Invesco Ltd. increased its stake in Teleflex by 1.2% during the second quarter. Invesco Ltd. now owns 135,516 shares of the medical technology company’s stock valued at $16,040,000 after acquiring an additional 1,659 shares during the period. Finally, EverSource Wealth Advisors LLC increased its stake in Teleflex by 108.1% during the second quarter. EverSource Wealth Advisors LLC now owns 1,003 shares of the medical technology company’s stock valued at $119,000 after acquiring an additional 521 shares during the period. 95.62% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on TFX. Raymond James Financial restated an “outperform” rating and set a $150.00 price target on shares of Teleflex in a research note on Friday, May 8th. Needham & Company LLC boosted their price target on Teleflex from $138.00 to $147.00 and gave the company a “buy” rating in a research note on Thursday, February 26th. Zacks Research upgraded Teleflex from a “strong sell” rating to a “hold” rating in a research note on Tuesday, April 28th. Royal Bank Of Canada upgraded Teleflex from a “sector perform” rating to an “outperform” rating and boosted their price target for the company from $135.00 to $155.00 in a research note on Friday, May 8th. Finally, Mizuho set a $140.00 price target on Teleflex in a research note on Friday, May 8th. Three equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Teleflex presently has a consensus rating of “Hold” and a consensus target price of $144.00.

Teleflex Trading Down 1.3%

TFX stock opened at $130.21 on Thursday. Teleflex Incorporated has a 1-year low of $100.18 and a 1-year high of $139.67. The firm has a market cap of $5.76 billion, a P/E ratio of -5.71, a P/E/G ratio of 0.98 and a beta of 0.82. The business’s 50 day moving average is $124.04 and its 200-day moving average is $117.15. The company has a current ratio of 2.55, a quick ratio of 2.03 and a debt-to-equity ratio of 0.82.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, May 7th. The medical technology company reported $1.39 earnings per share for the quarter, beating the consensus estimate of $1.21 by $0.18. Teleflex had a positive return on equity of 13.29% and a negative net margin of 35.88%.The company had revenue of $548.30 million for the quarter, compared to analyst estimates of $536.91 million. During the same period in the prior year, the company posted $1.44 EPS. The company’s revenue was up 32.3% compared to the same quarter last year. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. Equities analysts anticipate that Teleflex Incorporated will post 6.7 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Monday, May 25th will be paid a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 1.0%. The ex-dividend date is Friday, May 22nd. Teleflex’s dividend payout ratio is currently -5.96%.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.